Outcomes Of Patients (Pts) With Metastatic Urothelial Carcinoma (Muc) Following Discontinuation Of Enfortumab-Vedotin (Ev): Emergence Of A New Unmet Need.

JOURNAL OF CLINICAL ONCOLOGY(2020)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要